Prostate Management Diagnostics Inc.
Genetic markers for prostate cancer
This article was originally published in Start Up
Executive Summary
Prostate Management Diagnostics Inc. was formed to commercialize research on a series of genetic markers, discovered at The Genome Institute at the Washington University School of Medicine that could help determine whether a prostate cancer is indolent or aggressive in patients newly diagnosed with the disease.